6481 - 6490 of 7915 Results
Title
Year
-
OPENTitle: Systems-level neurophysiological state characteristics for drug evaluation in an animal model of levodopa-induced dyskinesiaJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 115Issue #: 3Start Page: 1713End Page: 1729Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/jn.00868.2015Best OA location URL: https://europepmc.org/articles/pmc4809970Citation Count: 22
-
RESTRICTEDTitle: Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative DiseasesJournal Name: Annual Review of Pharmacology and ToxicologyPublisher: Annual ReviewsVol: 56Issue #: 1Start Page: 489End Page: 510Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1146/annurev-pharmtox-010715-103548Best OA location URL: https://www.annualreviews.org/doi/pdf/10.1146/annurev-pharmtox-010715-103548Citation Count: 72
-
OPENTitle: LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rateJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-015-0066-zBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-015-0066-zCitation Count: 159
-
RESTRICTEDTitle: Tandem Mass Spectrometry Multiplex Analysis of Glucosylceramide and Galactosylceramide Isoforms in Brain Tissues at Different Stages of Parkinson DiseaseJournal Name: Analytical ChemistryPublisher: American Chemical Society (ACS)Vol: 88Issue #: 3Start Page: 1856End Page: 1863Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.analchem.5b04227Citation Count: 75
-
RESTRICTEDTitle: Activation Mechanism of LRRK2 and Its Cellular Functions in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2016Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1155/2016/7351985Best OA location URL: http://downloads.hindawi.com/journals/pd/2016/7351985.pdfCitation Count: 24
-
RESTRICTEDTitle: Autosomal dominant Parkinson's disease caused by SNCA duplicationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 22Issue #:Start Page: S1End Page: S6Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.09.007Best OA location URL: https://europepmc.org/articles/pmc4820832?pdf=renderCitation Count: 151
-
OPENTitle: Bioactive Flavonoids and Catechols as Hif1 and Nrf2 Protein Stabilizers - Implications for Parkinson’s DiseaseJournal Name: Aging and diseasePublisher: Aging and DiseaseVol: 7Issue #: 6Start Page: 745End Page: 745Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.14336/ad.2016.0505Best OA location URL: http://www.aginganddisease.org/EN/article/downloadArticleFile.do?attachType=PDF&id=147551Citation Count: 20
-
RESTRICTEDTitle: Biomarkers in Parkinson's disease: Advances and strategiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 22Issue #:Start Page: S106End Page: S110Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.09.048Best OA location URL: https://europepmc.org/articles/pmc5120398?pdf=renderCitation Count: 133
-
OPENTitle: Combined Optogenetic and Chemogenetic Control of NeuronsJournal Name: Methods in Molecular BiologyPublisher: Springer New YorkVol:Issue #:Start Page: 207End Page: 225Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/978-1-4939-3512-3_14Best OA location URL: https://europepmc.org/articles/pmc5149414?pdf=renderCitation Count: 30
-
OPENTitle: Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood‐based biomarkersJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 3Issue #: 1Start Page: 51End Page: 62Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.dadm.2016.03.002Best OA location URL: http://www.dadm.alzdem.com/article/S235287291630015X/pdfCitation Count: 72